drugset / Trial / NCT02477540
A Safety and Efficacy Study of Autologous Bone Marrow Derived Mesenchymal Stem Cells in Critical Limb Ischemia
NaSingle-groupOpen-labelTreatment
Summary
This clinical trial to study the Safety and Efficacy of Autologous Mesenchymal stem cells in critical limb ischemia.
Timeline
- Start
- 2019-12
- Primary completion
- 2020-06
- Completion
- 2020-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous bone marrow-derived mesenchymal stem cells | Cell therapy | 5e+07 cells | Intramuscular |